TABLE 1.
Formulation | Drug Concentration (M)* | EE (mol%)* | Calculated Payload (molecules/nm3 CPSNP×10−1)† |
---|---|---|---|
Cit-5-FU-CPSNP | 4.1 (±1.8) ×10−7 | 0.11 (±0.04) | 0.10 (±0.07) |
Cit-ATP:5-FU-CPSNP | 1.8 (±2.5) ×10−6 | 0.36 (±0.39) | 0.47 (±0.54) |
Cit-FUdR-CPSNP | 2.8 (±1.2) ×10−8 | <0.01 | 0.07 (±0.03) |
Cit-FdUMP-CPSNP | 3.0 (±1.4) ×10−4 | 41 (±16) | 32 (±16) |
Cit-dFdC-CPSNP | 1.9 (±0.6) ×10−9 | <0.01 | 0.01 (±0.01) |
Cit-dFdCMP-CPSNP | 2.3 (±0.4) ×10−5 | 22 (±6) | 3.6 (±1.6) |
Expressed as the mean ±95% CI of n=4–6 experimental replicates.
Particle number concentration by volume (particles/ml) is listed in Table S1 of supplementary information.